Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
SAILIFE
₹1,436.80
₹1432.00
₹1462.10
₹783.85
₹1485.00
Markets Today
Historical Performance
As of 25-08-2026 00:01, Sai Life Science Ltd. share price today is ₹0, with a change of ₹-1457.40 (-100.00%) from the previous close of ₹1457.4. The stock opened at ₹1457.6 and traded between ₹1432 and ₹1462.1, with a total traded volume of 263540 shares. The company has a market capitalization of ₹30942.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1485 and ₹783.85, respectively.
Sai Life Science Ltd. valuation metrics include a P/E ratio of 85.5, EPS of ₹16.63, and book value of ₹12.10. Profitability indicators show ROE of 14.04%. Sai Life Science Ltd. has reported revenue of ₹2250.36 Cr and net profit of ₹361.74 Cr.
Sai Life Science Ltd. technical indicators include Day RSI at 64.13, Day MFI at 75.63, Day ADX at 32.3. Additional indicators include Commodity Channel Index (CCI) at 84.1 and Williams %R at -16.68. Momentum indicators show Day MACD at 48.97, Day MACD Signal Line at 48.29, DayATR at 45.72. Rate of Change indicators for Sai Life Science Ltd. include ROC125 at 56.47 and ROC21 at 17.5.
Exponential moving averages include EMA5 at ₹1448.6, EMA10 at ₹1433.2, EMA12 at ₹1425.9, EMA20 at ₹1396.7, EMA26 at ₹1376.9, EMA50 at ₹1312.3, EMA100 at ₹1215.7, EMA200 at ₹1094.6. Simple moving averages include SMA5 at ₹1441.5, SMA10 at ₹1444.3, SMA20 at ₹1392.5, SMA30 at ₹1351, SMA50 at ₹1300.3, SMA100 at ₹1186.3, SMA150 at ₹1099.6, SMA200 at ₹1048.9.
Support levels for Sai Life Science are placed at First Support ₹1442.20, Second Support ₹1427.00, Third Support ₹1405.60. Resistance levels are seen at First Resistance ₹1478.80, Second Resistance ₹1500.20, Third Resistance ₹1515.40. Sai Life Science Ltd. shareholding pattern shows promoter holding at 34.53%, FII holding at 19.65%, DII holding at 0%, public holding at 13.11%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 546.73 | 594.34 | 549.18 | 526.67 | 483.04 |
| Operating Expense | 406.83 | 426.20 | 370.21 | 386.82 | 370.04 |
| Operating Profit | 139.90 | 168.14 | 178.97 | 139.85 | 113 |
| Depreciation | 42.13 | 41.16 | 40.60 | 36.21 | 34.32 |
| Interest | 5.98 | 6.16 | 8.06 | 7.70 | 10.70 |
| Tax | 24 | 34.32 | 32.84 | 27.92 | 19.61 |
| Net Profit | 71.34 | 102.53 | 97.63 | 82.95 | 58.37 |
₹1436.80
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 35.2 | 35.2 | 34.9 | 34.7 | 34.6 | 34.5 |
| FII | 12.4 | 14.6 | 22.5 | 21.4 | 21.2 | 19.6 |
| DII | 13.2 | 21.6 | 29.9 | 31.4 | 31.5 | 32.8 |
| Public | 39.2 | 28.6 | 12.6 | 12.5 | 12.7 | 13.1 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.99 L | 3.41 L | 58.35% |
| Week | 1.99 L | 3.75 L | 53.11% |
| 1 Month | 2.82 L | 5.87 L | 48.08% |
| 6 Month | 3.32 L | 6.65 L | 49.93% |
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Growth Stars: Strongest Annual EPS Performers
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
New 52 Week High
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹2,374.50 | ₹212.43 | ₹3,171 | ₹2,811.90 |
| % Change | 2.39% | 1.39% | -0.40% | -0.58% | 0.06% | -0.26% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹14,737.88 | ₹9,205.28 | ₹1,461.80 | ₹6,725.30 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹2,042.67 | ₹-313.62 | ₹386.22 | ₹1,128.79 |
| PE TTM | 99.10 | 85.20 | 48.20 | -90.70 | 67.20 | 41.20 |
| 1 Year Return | 255.61 | 5.9 | -8.55 | 10.85 | 122.56 | 44.03 |
| ROCE | 24.32 | 27.56 | 14.32 | 2.29 | 27.72 | 13.96 |
Laurus Labs Ltd.
₹ 1801.00
-0.06%
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
Biocon Ltd.
₹ 409.40
-1.48%
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
Granules India Ltd.
₹ 857.00
-0.13%
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
Wockhardt Ltd.
₹ 1902.00
+0.83%
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
Ipca Laboratories Ltd.
₹ 1921.00
+0.51%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2930.00
+0.96%
Pfizer Ltd.
₹ 4886.00
-1.85%
Abbott India Ltd.
₹ 26450.00
+0.84%
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
Lupin Ltd.
₹ 2188.00
-0.63%
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
Cipla Ltd.
₹ 1437.90
+0.40%
Emcure Pharmaceuticals Ltd.
₹ 1862.00
-0.05%
By signing up I certify terms, conditions & privacy policy